Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity

Conclusion: CTO is a non-invasive, reproducible and useful biomarker in the clinical practice; high CTO activity may predict extrapulmonary involvement of disease and could be useful to identify patients requiring pharmacological treatments.

Source: European Respiratory Journal - December 6, 2017 Category: Respiratory Medicine Authors: Cameli, P., Bargagli, E., Bennett, D., Bianchi, N., Refini, R. M., Rottoli, P., Cillis, G. Tags: Diffuse Parenchymal Lung Disease Source Type: research